data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Krystal Biotech
(NASDAQ:KRYS)
$73.41
2.06[2.89%]
Last update: 11:55AM
Day High/Low71.44 - 76.42
52 Week High/Low38.86 - 102.99
Open / Close71.44 / -
Float / Outstanding21.4M / 25.6M
Vol / Avg.102.2K / 178K
Mkt Cap1.9B
P/E-
50d Avg. Price59.95
Div / Yield-
Payout Ratio-
EPS-1.99
Total Float21.4M

Krystal Biotech (NASDAQ:KRYS), Quotes and News Summary

Krystal Biotech (NASDAQ: KRYS)

Day High/Low71.44 - 76.42
52 Week High/Low38.86 - 102.99
Open / Close71.44 / -
Float / Outstanding21.4M / 25.6M
Vol / Avg.102.2K / 178K
Mkt Cap1.9B
P/E-
50d Avg. Price59.95
Div / Yield-
Payout Ratio-
EPS-1.99
Total Float21.4M
Benzinga - Jun 22, 2022, 10:24AM
Benzinga - Jun 22, 2022, 7:00AM
Benzinga - May 24, 2022, 10:08AM
Benzinga - May 9, 2022, 5:03PM
Benzinga - Apr 11, 2022, 7:18AM
Benzinga - Mar 28, 2022, 11:01AM
Benzinga - Mar 1, 2022, 10:23AM
Benzinga - Feb 28, 2022, 10:31AM
Benzinga - Feb 28, 2022, 7:06AM
Benzinga - Jan 18, 2022, 1:28PM
Benzinga - Jan 18, 2022, 7:50AM
Benzinga - Nov 30, 2021, 8:18PM
Benzinga - Nov 30, 2021, 7:38AM
Benzinga - Nov 29, 2021, 4:20PM
Benzinga - Nov 29, 2021, 12:51PM
Benzinga - Nov 29, 2021, 8:05AM
Benzinga - Nov 29, 2021, 7:25AM
Benzinga - Nov 29, 2021, 7:02AM
Benzinga - Nov 19, 2021, 7:05AM
Benzinga - Nov 8, 2021, 7:13AM
Sector: Health Care.Industry: Biotechnology
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-08
REV
Q1 2022Est.ActualSurprise
EPS-0.990
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Krystal Biotech Questions & Answers

Q
How do I buy Krystal Biotech (KRYS) stock?
A

You can purchase shares of Krystal Biotech (NASDAQ: KRYS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Krystal Biotech's (KRYS) competitors?
Q
What is the target price for Krystal Biotech (KRYS) stock?
A

The latest price target for Krystal Biotech (NASDAQ: KRYS) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 78.00 expecting KRYS to rise to within 12 months (a possible 6.25% upside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Krystal Biotech (KRYS)?
A

The stock price for Krystal Biotech (NASDAQ: KRYS) is $73.41 last updated Today at July 6, 2022, 3:55 PM UTC.

Q
Does Krystal Biotech (KRYS) pay a dividend?
A

There are no upcoming dividends for Krystal Biotech.

Q
When is Krystal Biotech (NASDAQ:KRYS) reporting earnings?
A

Krystal Biotech’s Q2 earnings are confirmed for Monday, August 8, 2022.

Q
Is Krystal Biotech (KRYS) going to split?
A

There is no upcoming split for Krystal Biotech.

Q
What sector and industry does Krystal Biotech (KRYS) operate in?
A

Krystal Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.